Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-15 · accession 0001698998-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | 2025-03-15 | ICUI | Woolson Daniel | VP, GM-Infusion Capital | M - OptEx | $0.00 | +2,923 | 15.5K | +23% | $0 |
| D | 2025-03-17 | 2025-03-15 | ICUI | Woolson Daniel | VP, GM-Infusion Capital | F - Tax | $143.45 | -1,294 | 14.2K | -8% | -$185.6K |
| D | 2025-03-17 | 2025-03-15 | ICUI | Woolson Daniel | VP, GM-Infusion Capital | M - OptEx | $0.00 | -2,923 | 2,924 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-15 | M | A | 2,923 | $0.00 | 15,488 | D | — | — | (F1) These Securities are Performance-based Restricted Stock Units (PRSU). |
| 2 | Common | Common Stock | 2025-03-15 | F | D | 1,294 | $143.45 | 14,194 | D | — | — | |
| 3 | Derivative | Performance Shares | 2025-03-15 | M | D | 2,923 | $0.00 | 2,924 | D | $0.00 · — to 2026-03-15 | 2,923 Common Stock | (F1) These Securities are Performance-based Restricted Stock Units (PRSU). (F2) There is neither a purchase price nor an exercise price for the PRSUs. (F3) These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant. |